SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53 | +65.6% | 88,542 | +255.2% | 0.00% | – |
| Q2 2023 | $32 | -75.6% | 24,930 | -66.4% | 0.00% | -100.0% |
| Q1 2023 | $131 | -20.1% | 74,156 | +42.3% | 0.00% | 0.0% |
| Q4 2022 | $164 | -100.0% | 52,130 | -29.8% | 0.00% | -60.0% |
| Q3 2022 | $364,000 | -28.9% | 74,273 | -40.0% | 0.01% | 0.0% |
| Q2 2022 | $512,000 | +78.4% | 123,707 | +223.1% | 0.01% | +150.0% |
| Q4 2021 | $287,000 | -95.2% | 38,283 | -94.3% | 0.00% | -92.9% |
| Q3 2021 | $6,017,000 | -18.9% | 667,781 | +7.8% | 0.03% | -20.0% |
| Q2 2021 | $7,415,000 | +533.2% | 619,425 | +562.7% | 0.04% | +483.3% |
| Q1 2021 | $1,171,000 | +142.4% | 93,473 | +202.0% | 0.01% | +100.0% |
| Q4 2020 | $483,000 | -41.2% | 30,952 | -64.4% | 0.00% | -40.0% |
| Q3 2020 | $821,000 | +433.1% | 86,826 | +405.2% | 0.01% | +400.0% |
| Q2 2020 | $154,000 | -85.6% | 17,187 | -89.8% | 0.00% | -90.0% |
| Q1 2020 | $1,069,000 | +589.7% | 167,820 | +879.2% | 0.01% | +900.0% |
| Q3 2019 | $155,000 | -32.3% | 17,138 | -19.3% | 0.00% | -50.0% |
| Q2 2019 | $229,000 | +69.6% | 21,238 | +123.9% | 0.00% | +100.0% |
| Q2 2018 | $135,000 | -25.4% | 9,484 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $181,000 | -75.2% | 9,530 | -78.6% | 0.00% | -85.7% |
| Q4 2017 | $729,000 | -31.8% | 44,444 | -37.7% | 0.01% | -22.2% |
| Q3 2017 | $1,069,000 | +71.3% | 71,284 | +0.5% | 0.01% | +50.0% |
| Q2 2017 | $624,000 | +96.8% | 70,909 | +16.3% | 0.01% | +100.0% |
| Q1 2017 | $317,000 | +28.3% | 60,963 | -24.6% | 0.00% | +50.0% |
| Q4 2016 | $247,000 | +187.2% | 80,903 | +335.4% | 0.00% | +100.0% |
| Q3 2016 | $86,000 | -65.9% | 18,583 | -32.7% | 0.00% | -50.0% |
| Q4 2015 | $252,000 | -1.6% | 27,617 | -39.1% | 0.00% | 0.0% |
| Q3 2015 | $256,000 | +120.7% | 45,385 | +514.2% | 0.00% | +100.0% |
| Q1 2015 | $116,000 | -17.7% | 7,389 | -20.2% | 0.00% | 0.0% |
| Q4 2014 | $141,000 | -14.5% | 9,254 | -41.2% | 0.00% | 0.0% |
| Q3 2013 | $165,000 | – | 15,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |